Kiora Pharmaceuticals Valuation
| KPRX Stock | USD 0.51 0.04 7.27% |
Kiora Pharmaceuticals is undervalued. Kiora Pharmaceuticals secures a last-minute Real Value of $3.46 per share. The latest price of the firm is $0.51. Our model forecasts the value of Kiora Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -1.43, current valuation of 11.04 M, and Shares Owned By Insiders of 0.86 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Kiora Pharmaceuticals' valuation include:
Price Book 2.4702 | Enterprise Value 11 M | Enterprise Value Ebitda (1.03) | Price Sales 535.5867 | Forward PE 2.129 |
Undervalued
Today
Please note that Kiora Pharmaceuticals' price fluctuation is dangerous at this time. Calculation of the real value of Kiora Pharmaceuticals is based on 3 months time horizon. Increasing Kiora Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Kiora Pharmaceuticals is useful when determining the fair value of the Kiora stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kiora Pharmaceuticals. Since Kiora Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kiora Stock. However, Kiora Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.51 | Real 3.46 | Target 12.33 | Hype 0.51 | Naive 0.52 |
The real value of Kiora Stock, also known as its intrinsic value, is the underlying worth of Kiora Pharmaceuticals Company, which is reflected in its stock price. It is based on Kiora Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Kiora Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kiora Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kiora Pharmaceuticals helps investors to forecast how Kiora stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kiora Pharmaceuticals more accurately as focusing exclusively on Kiora Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kiora Pharmaceuticals' intrinsic value based on its ongoing forecasts of Kiora Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kiora Pharmaceuticals' closest peers. When choosing an evaluation method for Kiora Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Kiora Pharmaceuticals Investments |
|
Kiora Valuation Trend
Knowing Kiora Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Kiora Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Kiora Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Kiora Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Kiora Market Cap
Kiora Pharmaceuticals is rated third overall in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 112.77 Million. Kiora Pharmaceuticals retains roughly 13.39 Million in market capitalization claiming about 12% of equities under Health Care industry.Kiora Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Kiora Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Kiora Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kiora Pharmaceuticals competition to find correlations between indicators driving Kiora Pharmaceuticals's intrinsic value. More Info.Kiora Pharmaceuticals is rated fifth overall in price to book category among related companies. It is rated second overall in price to sales category among related companies fabricating about 216.82 of Price To Sales per Price To Book. At this time, Kiora Pharmaceuticals' Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Kiora Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kiora Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kiora Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kiora Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kiora Pharmaceuticals and how it compares across the competition.
About Kiora Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Kiora Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Kiora Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kiora Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Kiora Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Kiora Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kiora Pharmaceuticals. We calculate exposure to Kiora Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kiora Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -62.4 K | -59.3 K | |
| Pretax Profit Margin | (770.53) | (732.01) | |
| Operating Profit Margin | (780.98) | (741.93) | |
| Net Loss | (771.68) | (733.10) | |
| Gross Profit Margin | (17.94) | (17.05) |
8 Steps to conduct Kiora Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Kiora Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kiora Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kiora Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kiora Pharmaceuticals' revenue streams: Identify Kiora Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kiora Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kiora Pharmaceuticals' growth potential: Evaluate Kiora Pharmaceuticals' management, business model, and growth potential.
- Determine Kiora Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kiora Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Kiora Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Kiora Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.8 M | |
| Forward Price Earnings | 2.129 |
Kiora Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Kiora Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kiora we look at many different elements of the entity such as Kiora's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Kiora Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Kiora Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kiora Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kiora Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kiora Pharmaceuticals' worth.When determining whether Kiora Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiora Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiora Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiora Pharmaceuticals Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Kiora Stock analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 0.002 | Return On Assets (0.34) | Return On Equity (1.43) |
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.